Suppr超能文献

炎症性肠病患者早期动脉粥样硬化标志物表达增加。

Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease.

作者信息

Cappello Maria, Licata Anna, Calvaruso Vincenza, Bravatà Ivana, Aiello Alessandra, Torres Daniele, Della Corte Vittoriano, Tuttolomondo Antonino, Perticone Maria, Licata Giuseppe, Craxì Antonio, Cammà Calogero

机构信息

Gastroenterology and Hepatology Section, DIBIMIS, University of Palermo School of Medicine, Palermo, Italy.

Gastroenterology and Hepatology Section, DIBIMIS, University of Palermo School of Medicine, Palermo, Italy.

出版信息

Eur J Intern Med. 2017 Jan;37:83-89. doi: 10.1016/j.ejim.2016.10.004. Epub 2016 Oct 21.

Abstract

BACKGROUND & AIMS: Recent studies documented an increased cardiovascular risk in patients with inflammatory bowel disease (IBD). Our study aimed at investigating the prevalence of intima-media thickness (IMT) of the carotid arteries and the arterial stiffness indices as markers of early atherosclerosis in young IBD patients.

METHODS

We recruited 68 consecutive IBD patients, and 38 matched healthy controls less than 45years old (median age 31.6±8.1years). Clinical and demographic features, cardiovascular risk factors, history of cardiovascular events, concomitant therapies were registered on a dedicate database. Carotid IMT was evaluated by using high resolution B-mode ultrasonography. Arterial stiffness was assessed by measurement of carotid-femoral Pulse Wave Velocity (PWV) and Augmentation Index (AIx).

RESULTS

Total cholesterol (P<0.013) and LDL-cholesterol (P<0.019) levels were significantly lower in IBD patients compared to controls. Carotid IMT was higher in IBD than in controls (P<0.047), but there was no statistically significant difference among Crohn's Disease (CD) and Ulcerative Colitis (UC) patients. Moreover, PWV and AIx were significantly higher in patients as compared to controls (P<0.006 and P<0.004 respectively). No medication seemed to affect vascular measurements, though stiffness parameters were significantly higher in patients treated with 5-ASA (11.9 (9.7) vs 18.2 (10.2), P<0.021), suggesting a lack of efficacy of 5-ASA in protecting IBD patients from early atherogenesis.

CONCLUSIONS

Young IBD patients show an increase in subclinical markers of atherosclerosis. Future studies need to address whether these markers result in an increased risk of cardiovascular events in these patient.

摘要

背景与目的

近期研究表明,炎症性肠病(IBD)患者的心血管疾病风险增加。我们的研究旨在调查年轻IBD患者颈动脉内膜中层厚度(IMT)及动脉僵硬度指数作为早期动脉粥样硬化标志物的患病率。

方法

我们连续招募了68例IBD患者以及38例年龄小于45岁(中位年龄31.6±8.1岁)的匹配健康对照者。临床和人口统计学特征、心血管危险因素、心血管事件史、伴随治疗情况均记录在专用数据库中。采用高分辨率B型超声评估颈动脉IMT。通过测量颈动脉-股动脉脉搏波速度(PWV)和增强指数(AIx)评估动脉僵硬度。

结果

与对照组相比,IBD患者的总胆固醇(P<0.013)和低密度脂蛋白胆固醇(P<0.019)水平显著降低。IBD患者的颈动脉IMT高于对照组(P<0.047),但克罗恩病(CD)和溃疡性结肠炎(UC)患者之间无统计学显著差异。此外,患者的PWV和AIx显著高于对照组(分别为P<0.006和P<0.004)。尽管接受5-ASA治疗的患者僵硬度参数显著更高(11.9(9.7)对18.2(10.2),P<0.021),提示5-ASA在保护IBD患者免受早期动脉粥样硬化方面缺乏疗效,但似乎没有药物影响血管测量结果。

结论

年轻IBD患者的动脉粥样硬化亚临床标志物增加。未来研究需要探讨这些标志物是否会增加这些患者发生心血管事件的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验